Key hire
Dr Julie Cherrington Joins Xenome Board
Xenome appointed Dr Julie Cherrington, president of San Diego biopharmaceutical Phenomix and a Progen board member, as an independent director of the drug developer, effective 1 August 2009.
Company
Phenomix Corporation
San Diego
Funding history
Investors
Every investor coverage indicates participated in a round Phenomix Corporation raised.
What Phenomix Corporation bought
Companies Phenomix Corporation acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
People
| Name | Role | Sources |
|---|---|---|
| Dr Julie Cherrington | President (former) | GBS Ventures |
Coverage
Stories naming Phenomix Corporation. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.